Novo Nordisk

Novo Nordisk

Organization

Heard in 138 episodes across 56 shows since Oct 2025

Novo Nordisk A/S is a Danish multinational pharmaceutical and global healthcare company headquartered in Bagsværd, Denmark. It develops, manufactures, and markets medicines and related products for serious chronic diseases, especially diabetes and obesity, including insulin and GLP-1 treatments such as Wegovy; the podcast references concern its medicines, research, manufacturing standards, partnerships, and public-company performance.

Discussed inMarkets65%Business16%Politics12%Health & Science4%

Episodes

138
across 56 shows

This week

0
episodes on 0 shows

Expert statements

43
22 positive · 18 negative

Share of the conversation

Mentions of Novo Nordisk per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.05‰0.1‰0.15‰0.2‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Oct 140.05‰2
Oct 150.06‰1
Oct 160.08‰2
Oct 180.08‰2
Oct 190.09‰2
Oct 200.12‰5
Oct 210.11‰1
Oct 220.11‰1
Oct 230.12‰4
Oct 270.06‰1
Oct 280.06‰1
Oct 290.08‰3
Oct 300.05‰1
Oct 310.06‰1
Nov 10.10‰5
Nov 20.14‰5
Nov 30.15‰1
Nov 40.17‰5
Nov 50.16‰1
Nov 60.17‰3
Nov 80.14‰2
Nov 90.11‰2
Nov 100.13‰3
Nov 110.10‰1
Nov 130.09‰3
Nov 160.08‰3
Nov 170.07‰2
Nov 180.09‰3
Nov 190.10‰1
Nov 200.09‰2

The full trend: rank, tone and why it is trending →

Email alert

Email me when Novo Nordisk comes up on a podcast

One email a week at most, with the new episodes that mention Novo Nordisk. Free, no account needed, unsubscribe in one click.

What experts have said about Novo Nordisk

43 statements · 22 positive · 18 negative · 1 mixed · 2 neutral

  1. Dan NathanNeutralNov 4, 2026· CNBC's "Fast Money"

    Novo Nordisk needs a stronger pipeline to advance its stock valuation.

    “it's got to be pipeline oriented, I think, to get the stock to the next level.”

    Listen at 33:35

    Open the episode · Market’s Post-Election Surge… And Prognosis For Pharma, Health Care After Midterms 11/4/26
  2. Novo Nordisk trades roughly 12 times forward earnings after falling 40% from its 52-week high.

    “that stock is down 40%. And from its 52-week high, and it's trading roughly around 12 times forward earnings.”

    Listen at 3:26

    Open the episode · TIP857: S&P Global, Novo, Deckers Brands w/ Stig Brodersen, Tobias Carlisle, & Hari Ramachandra
  3. Novo Nordisk is a century-old, high-quality business.

    “it's a company that's 100 plus year old, great business.”

    Listen at 4:12

    Open the episode · TIP857: S&P Global, Novo, Deckers Brands w/ Stig Brodersen, Tobias Carlisle, & Hari Ramachandra

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

138 episodes featuring Novo Nordisk, newest first